glp 1 agonist drugs oral New GLP-1 Guidelines for Type 2 Diabetes in 2025 Oral GLP-1 for Weight Loss:

Its potential therapeutic applications have gathered attention due to its ability to stimulate tissue repair and promote healing processes [2]

In particular, the aromatization of circulating androgens to estrone in adipose tissue depots amplifies the deregulation of gonadotropin secretion with worsening of hyperandrogenism

References Sikiric P, Hahm KB, Blagaic AB, et al

The increase in CP expression was verified in the GSE49036 and GSE20164 datasets (Table 3)

De plus, une tude clinique pilote, publie en 2017, a mis en vidence une corrlation troite et positive entre les taux en GSH (dans le sang et le cerveau) et la prise de sulforaphane